|
Sorted by: Date | Top Results
|
|
Author |
|
Date |
| |
| |
| 1. |
Re: Jefferies just published price target of $13! 
I can't. I have a PDF of the report which doesn't
allow me to cut and paste. If anyone else out there
has a way to paste the report, please do. Thanks
Business & Finance > Investments > Stocks (A to Z) > Stocks C >
Cypress Bioscience Inc. (CYPB)
|
|
cockapoodash |
|
4-Nov-09 01:40 pm |
| |
| 2. |
Jefferies just published price target of $13!
Jefferies just published a price target of $13!
Business & Finance > Investments > Stocks (A to Z) > Stocks C >
Cypress Bioscience Inc. (CYPB)
|
|
cockapoodash |
|
3-Nov-09 11:13 pm |
| |
| 3. |
Lucky, can you start a new SCRIPTS thread
Lucky, the other thread is getting very long, can you
restart it as a new message? Thanks.
Business & Finance > Investments > Stocks (A to Z) > Stocks C >
Cypress Bioscience, Inc.
|
|
cockapoodash |
|
8-Sep-09 06:59 pm |
| |
| 4. |
Re: Open Enrollment
Different disease areas have differant rates of intrinsic
placebo affect. For example, there is a significant
effect in pain management -- if you think a pill will
make the pain better, your brain will...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
ACADIA Pharmaceuticals, Inc.
|
|
cockapoodash |
|
20-Aug-09 02:05 pm |
| |
| 5. |
Re: Conversations with IR
Not neccessarily,They know how many elected to continue
on in the open enrollment, but the trial is still
double blind, so there is limited information value
in this data. And if they...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
ACADIA Pharmaceuticals, Inc.
|
|
cockapoodash |
|
20-Aug-09 01:43 pm |
| |
| 6. |
Re: Open Enrollment
No,this is not my meaning. Of course patients electing
to continue on would get drug. But suppose 100 were
in the original trial and 50 got drug and 50 placebo
-- but...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
ACADIA Pharmaceuticals, Inc.
|
|
cockapoodash |
|
20-Aug-09 12:17 pm |
| |
| 7. |
Open Enrollment
I'm very long ACAD, but I did have a question on
the "Conversations with IR" thread. You
said they told you the vast majority of patients signed
up for open...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
ACADIA Pharmaceuticals, Inc.
|
|
cockapoodash |
|
20-Aug-09 12:00 pm |
| |
| 8. |
Re: The Shelf WAS not because they need money!
Those who listened to the call will note that they
could not have made it more clear that they have no
current plans for a secondary offering. They really
went out...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
ACADIA Pharmaceuticals, Inc.
|
|
cockapoodash |
|
5-Aug-09 11:53 pm |
| |
| 9. |
Re: Valuation Speculation Underestimates
You make an excellent point here as well. I would only
add that a p/e ratio is a statement about investor's
belief in the future growth potential of companies
-- yes analysts try to monetize this...
Business & Finance > Investments > Stocks (A to Z) > Stocks C >
Cypress Bioscience, Inc.
|
|
cockapoodash |
|
4-Aug-09 04:22 pm |
| |
| 10. |
Valuation Speculation Underestimates
The analysis of the possible value of CYPB to FRX at
the end of the previous post is quite interesting
and well thought out, but fails to give CYPB any credit
whatsoever for anything other than cash...
Business & Finance > Investments > Stocks (A to Z) > Stocks C >
Cypress Bioscience, Inc.
|
|
cockapoodash |
|
4-Aug-09 02:45 pm |
| |
| 11. |
Gordon Binder
Gordon Binder was CEO of Amgen until he retired and
began a VC firm. He was and is a strong believer in
ACAD. I suspect his abrupt resignation is due to a
family crises...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
ACADIA Pharmaceuticals, Inc.
|
|
cockapoodash |
|
28-Jul-09 08:01 pm |
| |
| 12. |
Re: Product Aquisition Is Smart Strategy
It is a horrible use of a salesforce to have one or
two products only. The startup and running costs for
reps is huge. Why in the world wouldn't you leverage
your salesforce if...
Business & Finance > Investments > Stocks (A to Z) > Stocks C >
Cypress Bioscience, Inc.
|
|
cockapoodash |
|
17-Apr-09 11:11 am |
| |
| 13. |
Product Aquisition Is Smart Strategy
CYPB have a salesforce, mostly on FRX's nickel.
Putting more products in the bags of their reps makes
great sense -- allowing CYPB to leverage their salesforce.
If you go to...
Business & Finance > Investments > Stocks (A to Z) > Stocks C >
Cypress Bioscience, Inc.
|
|
cockapoodash |
|
16-Apr-09 04:00 pm |
| |